Dermatology Diagnostic Devices and Therapeutics Market - Global Industry Analysis, Size, Share, Trends, Analysis, Growth, and Forecast 2017 - 2025
Global Dermatology Diagnostic Devices and Therapeutics Market: Snapshot
The global dermatology diagnostic devices and therapeutics market is driven by rising number of patients suffering from skin allergies, fungal infections, and skin cancer owing to pollution and changes in the environment. In 2013, a study conducted on clinical dermatology found that 25% population was suffering from skin diseases. Among them, 15% consulted general physician which shows growing awareness among these patients for treatment of skin disease. This has boosted the demand for advanced treatments and drugs. As a part of this, key players have made investments in research and development (R&Ds) of advanced drugs.
For instance, recently, in March 2017, The US Food and Drug Administration (FDA) approved Dupixent (dupilumab) injection to treat moderate-to-severe eczema found in adults. Earlier, there were very few options to treat this disease. This is a product of one of the player operating in the market – Sanofi and Regeneron Pharmaceuticals, Inc. Sanofi Genzyme, which is the business unit of Sanofi and Regeneron, will hold the market for the drug in the US. Dupixent is the first biologic medicine approved by FDA for treatment of atopic dermatitis (AD) – eczema. This drug will be applicable when the disease cannot be controlled with topical prescription therapies or in the conditions where therapies are not advisable.
Dupixent is monoclonal antibody mainly designed for signaling two overactive proteins – IL-4 and IL-13 – which are majorly responsible for inflammation in an AD. It comes in the form of a pre-filled syringe which can be administrated by patients after the initial dose, it can be injected for every alternate week. Use of topical corticosteroids is not mandatory for injecting Dupixent. However, the drug is not suitable for patients who have dupilumab allergies or other ingredients present in the drug.
Currently, this drug is available in the US market. The launch of the drug is beneficial for the market to gather revenue substantially.
Global Dermatology Diagnostic Devices and Therapeutics Market: Overview
The global dermatology diagnostic devices and therapeutics market is gaining momentum due to the high prevalence of skin diseases and disorders. The trajectory of the global market will be decided by increasing pool of geriatrics, patent expirations in the offing, and the prevalence of chronic ailments. The research report points out that supportive governmental initiatives and increasing activities to raise awareness about dangerous skin disorders are expected to work in favor of the global market.
Global Dermatology Diagnostic Devices and Therapeutics Market: Drivers and Trends
The growing number of geriatrics is the key growth driver for the global dermatology diagnostic devices and therapeutics market. Aging skin is more prone to various types of skin cancer, invasive melanoma, and other diseases and disorders. Thus, increasing number of aged people have augmented the demand for dermatology diagnostic devices and therapeutics for diagnosing and treating the various conditions.
Rising pollution, changing lifestyles, and increasing usage of cosmetics has also resulted in high prevalence of acne and psoriasis, which in turn has had a positive influence on the global market. Furthermore, the increasing expenditure on healthcare and the introduction of new and improved dermatology diagnostics and devices and therapeutics have led to the growth of the overall market.
Global Dermatology Diagnostic Devices and Therapeutics Market: Market Potential
Several players are trying to incorporate technology used for developing diagnostic devices into smartphones and tablets to improve the rate of diagnostics. For instance, Agfa HealthCare launched its web-enabled mobile image management technology known as ICIS, which it plans to integrate into iPhones, iPads, and other mobile digital devices. Offering healthcare through smartphones is an important step in the way of medical devices are poised to evolve for the future. This is expected to provide the patient, caregivers, and physicians a chance to capture images at any point and from any location and publishing them on safely guarded EHRs.
Such initiatives are aimed towards improving diagnostics, patient engagement, and making healthcare even more reachable. Players in the global dermatology diagnostic devices and therapeutics market are expected to focus on making healthcare easy and accessible to win bigger user bases in the near future.
Global Dermatology Diagnostic Devices and Therapeutics Market: Regional Outlook
In terms of geography, the global dermatology diagnostic devices and therapeutics market is segmented into the Middle East and North Africa, Latin America, Asia Pacific, Europe, North America, and Rest of the World. Of these, North America is expected to dominate the global market due to a higher level of awareness about skin disorders and diseases in the region. The dominance of this region will be boosted by the excellent access to healthcare and supportive reimbursement policies. The well-organized healthcare sector is also projected favor the regional market’s growth in the near future.
Europe is expected to follow North America’s lead in the coming years, while Asia Pacific will be seen as an important emerging market. The huge pool of geriatrics in Asia Pacific and the ever-increasing unmet medical needs in the developing countries of the region will also make a significant contribution to the soaring revenue of the overall market.
Key Players Mentioned in the Report are:
Some of the key players operating in the global dermatology diagnostics devices and therapeutics market are Valeant Pharmaceuticals International, Inc., Agfa-Gevaert N.V., Astellas Pharma, Inc., Cutera, Inc., Novartis International AG, Galderma S.A., Dino-Lite Europe/IDCP B.V., Genentech, LEO Pharma A/S, Michelson Diagnostics Ltd., and others.
The reports at TMR Research provide qualitative solutions that break the barriers of doubt or uncertainties when the stakeholders plan to expand their growth reach. The researchers compile the necessary information that enlightens the CXOs about the current growth opportunities in a specific market and enables them to make the most of the opportunities.
TMR Research is a leader in developing well-researched reports. The expertise of the researchers at TMR Research makes the report stand out from others. TMR Research reports help the stakeholders and CXOs make impactful decisions through a unique blend of innovation and analytical thinking. The use of innovation and analytical thinking while structuring a report assures complete and ideal information of the current status of the market to the stakeholders.
TMR Research has rich experience in developing state-of-the-art reports for a wide array of markets and sectors. The brilliance of the experts at TMR Research and their alacrity to conduct thorough research and create phenomenal reports makes TMR Research better than others.
5-Point Growth Formula
The 5-point growth formula developed by TMR Research provides an insight to the stakeholders and CXOs about the current situation in the market. The growth formula makes the report a perfect companion for the stakeholders and CXOs.
The 5-point growth formula includes the following points:
Current and Future Threats
Along with studying the opportunities necessary for growth, threats are also an important aspect to look upon for the companies and stakeholders in a specific sector. TMR Research studies every negative aspect that will hinder the growth of a specific area of business and includes it in the report. The stakeholders and CXOs will have the benefit of assessing the threat and take the necessary steps to prevent the hindrance caused due to the threats.
Accurate Trend Analysis
Keeping up with the latest trends is crucial in any business or sector. While stakeholders are aware of the trends that are on the surface, TMR Researchers find trends that are deeply entrenched in the particular market or sector. The reports are constantly updated with the latest trends so that the stakeholders and CXOs can derive benefits from the trends and generate good revenues.
Demography forms an important part of the growth pattern of all the markets. Diving deep into the demographics enables maximum output from specific areas. The TMR Research team assesses every region and picks out the vital points that have a large impact on the growth of a market.
The analysts at TMR Research conduct an all-round analysis on the competitive landscape of the market. The observations recorded by the analysts are added to the reports so that every stakeholder gets a glimpse of the competitive scenario and frame their business plans according to the situation.
The COVID-19 outbreak has changed the growth projections of numerous sectors and businesses. The analysts at TMR Research have conducted a conscientious survey on the markets after the pandemic struck. The analysts have put forth their brilliant and well-researched opinions in the report. The opinions will help the stakeholders to plan their strategy accordingly.
The reports offer answers to the top 7 questions that revolve around the growth of the market
Flat 10% discount on Single User License if you prebook this report
Flat 10% discount on Multiple User License if you prebook this report
Flat 10% discount on Corporate License if you prebook this report